The α2,3-selective potentiators of GABAA receptors, KRM-II-81 and MP-III-80, produce anxiolytic-like effects and block chemotherapy-induced hyperalgesia in mice without tolerance development-Reference-Cited by-同舟云学术

The α2,3-selective potentiators of GABAA receptors, KRM-II-81 and MP-III-80, produce anxiolytic-like effects and block chemotherapy-induced hyperalgesia in mice without tolerance development

Published:2020-09 Issue: Volume:196 Page:172996
ISSN:0091-3057
Container-title:Pharmacology Biochemistry and Behavior
language:en
Short-container-title:Pharmacology Biochemistry and Behavior

Author:

Biggerstaff A.,Kivell B.,Smith J.L.,Mian Md Y.,Golani L.K.,Rashid F.,Sharmin D.,Knutson D.E.,Cerne R.,Cook J.M.,Witkin J.M.

Publisher

Elsevier BV

Subject

Behavioral Neuroscience,Biological Psychiatry,Clinical Biochemistry,Pharmacology,Toxicology,Biochemistry

Reference61 articles.

1. Reducing abuse liability of GABAA/benzodiazepine ligands via selective partial agonist efficacy at alpha1 and alpha2/3 subtypes;Ator;J. Pharmacol. Exp. Ther.,2010

2. Generalized anxiety disorder and pain;Bandelow;Mod. Trends Pharmacopsychiat.,2015

3. Opioid complications and side effects;Benyamin;Pain Phys.,2008

4. Improvements in the pharmacological profile of diazepam by KRM-II-81, an imidizodiazepine positive allosteric modulator of α2/3-containing GABAA receptors: preclinical data predict enhanced efficacy for epilepsy, chronic pain, anxiety, and depression;Cerne;Pharmaceut. Sci. Biomed. Anal. J.,2019

5. The opioid crisis and the future of addiction and pain therapeutics;Coussens;J. Pharmacol. Exp. Ther.,2019

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. BAER‐101, a selective potentiator of α2‐ and α3‐containing GABA_A receptors, fully suppresses spontaneous cortical spike‐wave discharges in Genetic Absence Epilepsy Rats from Strasbourg (GAERS);Drug Development Research;2024-02-21

2. KRM–II–81 suppresses epileptifom activity across the neural network of cortical tissue from a patient with pharmacoresistant epilepsy;Heliyon;2024-01

3. Preclinical research in paclitaxel-induced neuropathic pain: a systematic review;Frontiers in Veterinary Science;2023-12-18

4. Therapeutic effects of KRM-II-81, positive allosteric modulator for α2/3 subunit containing GABAA receptors, in a mouse model of Dravet syndrome;Frontiers in Pharmacology;2023-10-02

5. Structural Analogs of the GABAkine KRM-II-81 Are Orally Bioavailable Anticonvulsants without Sedation;Journal of Pharmacology and Experimental Therapeutics;2023-02-06